ANTHONY GUNAWAN: Open Payments
NPI 1811543531 · LAKIN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,575 in 66 payments from 12 companies in 2025. Trend: 2023 $4,184 · 2024 $2,537 · 2025 $1,575
Food & beverage: $1,575
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 12 | $316 |
| Boston Scientific Corporation | 11 | $238 |
| Abbott Laboratories | 5 | $234 |
| MML US, Inc. | 11 | $233 |
| Collegium Pharmaceutical, Inc. | 10 | $157 |
| Medtronic, Inc. | 6 | $150 |
| ABBVIE INC. | 3 | $66 |
| Globus Medical, Inc. | 3 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| Averitas Pharma Inc. | 1 | $38 |
Products named: JOURNAVX, ReActiv8, ETERNA, Belbuca, Intracept, INTELLIS ADAPTIVESTIM, INCEPTIV, PROCLAIM.
Industry payments across KS — which companies pay providers there.
